Oragenics completes 1-for-60 reverse stock split to maintain NYSE American listing

ORAGENICS INC

Reverse stock split effective 5:00 p.m. EST on Jan 20, 2023; shares began trading split-adjusted Jan 23.
Authorized shares reduced from 250M to ~4.17M; outstanding from ~117.66M to ~1.96M post-split.
No fractional shares issued; any fractional interest rounded up to one whole share.
Split approved solely by Board under Florida law, no shareholder vote required.
Reason: to meet NYSE American continued listing standards and reduce risk of delisting due to low stock price.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.95

ORAGENICS INC: The company filed Articles of Amendment to effect a 1-for-60 reverse stock split of common stock, reducing authorized shares from 250,000,000 to 4,166,666 and outstanding shares from 117,662,247 to approximately 1,961,037 (effective 2023-01-20).

Change: charter amendment
Effective: 2023-01-20

Exact text from the filing

Articles of Amendment to our Amended and Restated Articles of Incorporation to effect the 1-for-60 reverse split of the Company’s authorized shares of common stock and issued and outstanding shares of common stock (the “Articles of Amendment”) were filed with the Secretary of State of the State of Florida.

View on SEC.gov

59 governance changes filed in the last 30 days. Browse all governance changes →

ORAGENICS INC filing history →

Source: SEC EDGAR

accession 0001493152-23-002194

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.